ConductScience.org, home

Paper39679205

Treatment outcomes in NTM-PD in a high TB burden context.

Kang S and 3 others. IJTLD Open, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Treatment outcomes in NTM-PD in a high TB burden context. Papers, record 39679205. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39679205

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment outcomes in NTM-PD in a high TB burden context.
PubMed
Journal
IJTLD Open
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
1.01, provisional
iCite
Revised in PubMed
2025-01-04
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kang SS
2Schmidt JEJ E
3Chen II
4Tiberi SS

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133926548Nontuberculous mycobacteria in China: incidence and antimicrobial resistance spectrum from a nationwide survey.Infect Dis Poverty2021https://conductscience.org/library/papers/33926548PubMed
232070324Etiology and characteristics of patients with bronchiectasis in Taiwan: a cohort study from 2002 to 2016.BMC Pulm Med2020https://conductscience.org/library/papers/32070324PubMed
332636299Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.Eur Respir J2020https://conductscience.org/library/papers/32636299PubMed
432814943Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management.J Infect Dis2020https://conductscience.org/library/papers/32814943PubMed
533333637[Guidelines for bronchial asthma prevent and management(2020 edition) Asthma group of Chinese Throacic Society].Zhonghua Jie He He Hu Xi Za Zhi2020https://conductscience.org/library/papers/33333637PubMed
625614169The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease.Eur Respir J2015https://conductscience.org/library/papers/25614169PubMed
733832019[Expert consensus on the diagnosis and treatment of adult bronchiectasis in China].Zhonghua Jie He He Hu Xi Za Zhi2021https://conductscience.org/library/papers/33832019PubMed
830687747In Vitro Susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum Isolates to 30 Antibiotics.Biomed Res Int2018https://conductscience.org/library/papers/30687747PubMed
929567726Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement.Eur Respir J2018https://conductscience.org/library/papers/29567726PubMed
1032527504Treatment for Mycobacterium abscessus complex-lung disease.J Formos Med Assoc2020https://conductscience.org/library/papers/32527504PubMed
1112709349In vitro activity of linezolid against slowly growing nontuberculous Mycobacteria.Antimicrob Agents Chemother2003https://conductscience.org/library/papers/12709349PubMed
1232870060Summary for Clinicians: 2020 Clinical Practice Guideline Summary for the Treatment of Nontuberculous Mycobacterial Pulmonary Disease.Ann Am Thorac Soc2020https://conductscience.org/library/papers/32870060PubMed
1334390707Outcomes of Resectional Thoracic Surgery for the Treatment of Pulmonary Nontuberculous Mycobacterial Disease in 105 Patients in the United States.Chest2022https://conductscience.org/library/papers/34390707PubMed
1430880280M ycobacterium abscessus pulmonary disease: individual patient data meta-analysis.Eur Respir J2019https://conductscience.org/library/papers/30880280PubMed
1533782057The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.BMJ2021https://conductscience.org/library/papers/33782057PubMed
1617277290An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.Am J Respir Crit Care Med2007https://conductscience.org/library/papers/17277290PubMed
1730071548Geographic Distribution of Nontuberculous Mycobacteria Isolated from Clinical Specimens: A Systematic Review.Semin Respir Crit Care Med2018https://conductscience.org/library/papers/30071548PubMed
1832617011Antimicrobial Susceptibility of Mycobacterium abscessus Complex Clinical Isolates from a Chinese Tertiary Hospital.Infect Drug Resist2020https://conductscience.org/library/papers/32617011PubMed
1931506134Prevalence and risk factors of pulmonary nontuberculous mycobacterial infections in the Zhejiang Province of China.Epidemiol Infect2019https://conductscience.org/library/papers/31506134PubMed
2033839127Outcomes of Surgical Treatment for Mycobacterium abscessus Complex Pulmonary Disease.Ann Thorac Surg2022https://conductscience.org/library/papers/33839127PubMed

See all 30 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42064296Predictive Value of Nutritional Status in Sputum Culture Conversion Among Patients with Nontuberculous Mycobacterial Pulmonary Disease: A Retrospective Cohort Study.Infect Drug Resist2026https://conductscience.org/library/papers/42064296PubMed
41994466Development and internal validation of a LASSO-based clinical prediction model for nontuberculous mycobacterial pulmonary disease versus pulmonary tuberculosis.Front Med (Lausanne)2026https://conductscience.org/library/papers/41994466PubMed
41843721Real-World Experience of Prolonged Treatment for Treatment-Refractory Nontuberculous Mycobacterial Pulmonary Disease: Benefits and Harms of Extending Therapy beyond 24 Months.Respiration2026https://conductscience.org/library/papers/41843721PubMed
41244776Case Report: First pulmonary infection caused by Mycobacterium colombiense in a non-immunosuppressed host with bronchiectasis: diagnosis facilitated by synergistic mNGS and culture.Front Med (Lausanne)2025https://conductscience.org/library/papers/41244776PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39679205

GET https://conductscience.org/api/papers/v1/39679205/references?page=2